Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
about
Stem cell therapy for chronic ischaemic heart disease and congestive heart failureProgramming and reprogramming a human heart cellCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsAdult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled TrialsStem cell therapy for chronic ischaemic heart disease and congestive heart failure.A role of myocardial stiffness in cell-based cardiac repair: a hypothesis.Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis.Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis.Clinical trials of cardiac repair with adult bone marrow- derived cells.The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis.Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study.Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialBone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.Cardiac cell repair therapy: a clinical perspective.Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease.Stem cell therapy for cardiac disease.Autologous cell therapy for cardiac repair.Myocardial regeneration in heart failure: integrated development of biological therapeutic approaches.Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.Regenerating cardiac cells: insights from the bench and the clinic.Stem cell therapy for heart disease.Cellular Therapy for Heart Failure.Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients.Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease.Global position paper on cardiovascular regenerative medicineMeasuring Treatment Effects in Clinical Trials Using Cardiac MRI
P2860
Q24194988-66A85B76-6F2A-4744-8668-9CC17DE1F5A3Q26823933-D5C00FF8-FC30-4A9B-9064-17E854CDA85AQ27001159-F5395912-13DA-4D1E-B939-78A3966C2460Q28082162-DF9D5BD6-FD87-42CD-9BA7-21B2ED153295Q30239945-53EC7136-940C-4CC5-ACDA-5E84E541EAA6Q33412550-44E98DAD-A13A-4FF4-A1D5-4A42895F0466Q33490304-9A11392E-A9D3-4A20-A28B-4642FD13F44CQ33552606-4B604F30-62BA-4192-A95C-9D8DAB241B80Q34043802-C58210C9-8C5F-44E9-B281-30EDA1F0E60FQ34786321-20BDA358-E395-43BC-B280-0AEE54E470E4Q35079018-63928167-929D-4E75-A4EC-30F3AA842D27Q35290282-F5A1A4C3-8C7B-4757-B312-E57C2B4A0C43Q35875311-A5D222C3-C4DF-4B8E-8218-B9C3D58417DFQ36694346-ADB17B37-83B3-4BD4-A6AB-AF83038BB11FQ37194005-7069F443-4B04-48C1-8BF0-DC16C81BBF36Q37371934-3569A886-0E6E-4E48-9374-31D6D90C374CQ37598908-CD8DCA2F-437F-45A5-B6E6-A9691E0DB1C2Q37827158-AD4ED60B-708C-42E5-A9EB-A9002742FB18Q37837891-31D87815-5AC4-4C12-B9E5-86D1C5ACB94BQ37923971-50392921-99F1-4241-928A-97E9AF094997Q38021450-253C752D-9E04-43BA-9B19-034F1EBC7D64Q38032473-1F3878FA-64D8-43AF-8F00-78604A9C5B09Q38114860-89ADDAA9-B6D4-4CD0-B313-33115366AEC8Q38859871-730002F5-5FA0-4591-AF75-9619DF213FD1Q41522029-110C36D5-FADC-4FE1-9C39-4498C2933456Q48270981-5B780A74-8487-4E47-B889-C391143D8813Q49288386-F43CD238-7053-45C3-B492-CC5AC2C0355AQ56985687-C55065C8-8BD4-4CD9-BC2E-CB8380C9BAB5Q57448743-6AFA8A57-5EA0-4194-AC57-4AD7C191C11A
P2860
Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Administration of intracoronar ...... n improves diastolic function.
@ast
Administration of intracoronar ...... n improves diastolic function.
@en
Administration of intracoronar ...... n improves diastolic function.
@nl
type
label
Administration of intracoronar ...... n improves diastolic function.
@ast
Administration of intracoronar ...... n improves diastolic function.
@en
Administration of intracoronar ...... n improves diastolic function.
@nl
prefLabel
Administration of intracoronar ...... n improves diastolic function.
@ast
Administration of intracoronar ...... n improves diastolic function.
@en
Administration of intracoronar ...... n improves diastolic function.
@nl
P2093
P921
P356
P1433
P1476
Administration of intracoronar ...... n improves diastolic function.
@en
P2093
P304
P356
10.1136/HRT.2007.137919
P407
P577
2008-04-01T00:00:00Z